Target intelligence / Profile preview

Zinc finger protein GLIS2 (GLIS2)

Target
GLIS2
Molecular classification
Transcription factor, Krüppel-like zinc finger protein family
01

Overview

Zinc finger protein GLIS2 (GLIS2) is a nuclear transcription factor belonging to the Krüppel-like family of C2H2-type zinc finger proteins.[1][2][3][4][7] It contains five tandem zinc finger motifs and operates both as a repressor and activator of gene transcription depending on cell context. GLIS2 is critical in the maintenance of normal kidney structure (inhibiting apoptosis and fibrosis), neuronal differentiation, and the regulation of important developmental signaling pathways such as Hedgehog and Wnt.[1][3][4][7] High expression is observed in the kidney, and loss-of-function mutations in GLIS2 cause nephronophthisis type 7 (NPHP7), a genetic kidney disease. Experimental findings support a potential therapeutic role for GLIS2 inhibition in polycystic kidney disease, but it is not currently an established drug target.[6]

Other names
GLIS family zinc finger 2Gli-similar 2GLIS2NKLNPHP7Neuronal Krueppel-like proteinNephrocystin-7Kruppel-like zinc finger protein GLIS2
02

Mechanism of action

Transcriptional repression or activation through direct DNA binding at target gene promoters Pharmacological inhibition (using antisense oligonucleotides) to suppress expression, used experimentally to reduce cyst formation in PKD mouse models[6]

03

Biological functions

Regulation of gene transcription (activator and repressor)Inhibition of the Hedgehog signaling pathwayRepression of Wnt signaling pathway target genesRegulation of kidney morphogenesis and maintenance of epithelial cell phenotypePromotion of neuronal differentiation
04

Disease associations

Nephronophthisis (NPHP7) – autosomal recessive kidney diseasePotential role in polycystic kidney disease (PKD)Associated with acute megakaryoblastic leukemia (in children without Down syndrome)Possible involvement in cancer
05

Safety considerations

Potential risk of disrupting essential gene regulation in kidney and neural developmentPossible off-target effects when using antisense oligonucleotides or gene-modifying drugs targeting transcription factors
06

Interacting drugs

Antisense oligonucleotides (reported experimental pharmacological targeting in PKD mouse models)[6]

1 more in the full profile.

07

Biomarkers

GLIS2 transcript and protein levels (used as a biomarker for polycystin activity and cyst formation in kidney disease preclinical models)[6]

Beyond the preview

Go deeper on Zinc finger protein GLIS2 (GLIS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger protein GLIS2 (GLIS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call